These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10961720)

  • 21. The heterogeneity of bone disease in cirrhosis: a multivariate analysis.
    Crawford BA; Kam C; Donaghy AJ; McCaughan GW
    Osteoporos Int; 2003 Dec; 14(12):987-94. PubMed ID: 14504696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lower Bone Mass and Higher Bone Resorption in Pheochromocytoma: Importance of Sympathetic Activity on Human Bone.
    Kim BJ; Kwak MK; Ahn SH; Kim H; Lee SH; Song KH; Suh S; Kim JH; Koh JM
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2711-2718. PubMed ID: 28582552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients.
    Okuno S; Inaba M; Kitatani K; Ishimura E; Yamakawa T; Nishizawa Y
    Osteoporos Int; 2005 May; 16(5):501-9. PubMed ID: 15309383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection.
    Schiefke I; Fach A; Wiedmann M; Aretin AV; Schenker E; Borte G; Wiese M; Moessner J
    World J Gastroenterol; 2005 Mar; 11(12):1843-7. PubMed ID: 15793878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
    Välimäki MJ; Tiihonen M; Laitinen K; Tähtelä R; Kärkkäinen M; Lamberg-Allardt C; Mäkelä P; Tunninen R
    J Bone Miner Res; 1994 May; 9(5):631-7. PubMed ID: 8053391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of hormone replacement therapy in postmenopausal women on urinary C-telopeptide and N-telopeptide of type I collagen, new markers of bone resorption.
    Taga M; Uemura T; Minaguchi H
    J Endocrinol Invest; 1998 Mar; 21(3):154-9. PubMed ID: 9591210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone mineral density assessed by dual-energy X-ray absorptiometry in patients with viral or alcoholic compensated cirrhosis. A prospective study.
    Mahmoudi A; Sellier N; Reboul-Marty J; Chalès G; Lalatonne Y; Bourcier V; Grando V; Barget N; Beaugrand M; Trinchet JC; Ganne-Carrié N
    Clin Res Hepatol Gastroenterol; 2011 Nov; 35(11):731-7. PubMed ID: 21873139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sclerostin Expression in Bile Ducts of Patients With Chronic Cholestasis May Influence the Bone Disease in Primary Biliary Cirrhosis.
    Guañabens N; Ruiz-Gaspà S; Gifre L; Miquel R; Peris P; Monegal A; Dubrueil M; Arias A; Parés A
    J Bone Miner Res; 2016 Sep; 31(9):1725-33. PubMed ID: 27019303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone mineral density of the spine and femur in a group of healthy Moroccan men.
    El Maghraoui A; Ghazi M; Gassim S; Mounach A; Ghozlani I; Nouijai A; Achemlal L; Bezza A; Dehhaoui M
    Bone; 2009 May; 44(5):965-9. PubMed ID: 19168162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone density, bone turnover, and hormone levels in men over age 75.
    Kenny AM; Gallagher JC; Prestwood KM; Gruman CA; Raisz LG
    J Gerontol A Biol Sci Med Sci; 1998 Nov; 53(6):M419-25. PubMed ID: 9823745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of secondary osteoporosis due to lobular cholestasis in non-cirrhotic primary biliary cholangitis.
    Seki A; Ikeda F; Miyatake H; Takaguchi K; Hayashi S; Osawa T; Fujioka SI; Tanaka R; Ando M; Seki H; Iwasaki Y; Yamamoto K; Okada H
    J Gastroenterol Hepatol; 2017 Sep; 32(9):1611-1616. PubMed ID: 28114749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Handgrip strength as a predictor of bone mineral density in outpatients with cirrhosis.
    Santos LA; Lima TB; Augusti L; Franzoni Lde C; Yamashiro Fda S; Bolfi F; Nunes Vdos S; Dorna Mde S; de Oliveira CV; Caramori CA; Silva GF; Romeiro FG
    J Gastroenterol Hepatol; 2016 Jan; 31(1):229-34. PubMed ID: 26212461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
    Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
    J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal changes of bone mineral density and metabolism in antiretroviral-treated human immunodeficiency virus-infected children.
    Mora S; Zamproni I; Beccio S; Bianchi R; Giacomet V; Viganò A
    J Clin Endocrinol Metab; 2004 Jan; 89(1):24-8. PubMed ID: 14715822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bone metabolism in dialysis patient assessed by biochemical markers and densitometry].
    Małyszko J; Brzósko S; Wołczyński S; Małyszko JS; Myśliwiec M
    Pol Arch Med Wewn; 2003 Sep; 110(3):967-72. PubMed ID: 14699689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential role of insulin-like growth factor 1, insulin-like growth factor binding protein 3 and bone mineral density in patients with chronic hepatitis C virus in Cairo, Egypt.
    Raslan HM; Elhosary Y; Ezzat WM; Rasheed EA; Rasheed MA
    Trans R Soc Trop Med Hyg; 2010 Jun; 104(6):429-32. PubMed ID: 20189618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bone mineral density in patients with liver cirrhosis].
    Topcheeva ON; Drozdov VN; Embutnieks IuV; Viazhevich IuV
    Eksp Klin Gastroenterol; 2009; (8):51-5. PubMed ID: 20469679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
    Koruk M; Onuk MD; Akçay F; Savas MC
    Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between chronic hepatitis C virus infection and bone mineral density.
    Lin JC; Hsieh TY; Wu CC; Chen PJ; Chueh TH; Chang WK; Chu HC
    Calcif Tissue Int; 2012 Dec; 91(6):423-9. PubMed ID: 23052227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone mineral density and biochemical markers of bone turnover in healthy elderly men and women.
    Krall EA; Dawson-Hughes B; Hirst K; Gallagher JC; Sherman SS; Dalsky G
    J Gerontol A Biol Sci Med Sci; 1997 Mar; 52(2):M61-7. PubMed ID: 9060971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.